Sandoz Group AG (FRA:D8Y0) Other Net Income (Loss) : €0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Other Net Income (Loss)?

Sandoz Group AG's Other Net Income (Loss) for the six months ended in Dec. 2024 was €0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was €0 Mil.

Sandoz Group AG's quarterly Other Net Income (Loss) declined from Dec. 2023 (€0 Mil) to Jun. 2024 (€0 Mil) but then stayed the same from Jun. 2024 (€0 Mil) to Dec. 2024 (€0 Mil).

Sandoz Group AG's annual Other Net Income (Loss) increased from Dec. 2022 (€0 Mil) to Dec. 2023 (€0 Mil) but then declined from Dec. 2023 (€0 Mil) to Dec. 2024 (€-0 Mil).

Sandoz Group AG Other Net Income (Loss) Historical Data

The historical data trend for Sandoz Group AG's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Other Net Income (Loss) Chart

Sandoz Group AG Annual Data

Trend

Dec22

Dec23

Dec24

Other Net Income (Loss)

Sandoz Group AG Semi-Annual Data
	Dec22	Jun23	Dec23	Jun24	Dec24
Other Net Income (Loss)	-	-	-	-	-

Sandoz Group AG Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0 Mil.

Sandoz Group AG Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sandoz Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (FRA:D8Y0) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

SDZXF:USA SDZNY:USA SDZz:UK 0SAN:UK SDZ:Switzerland

Address

Centralbahnstrasse 4, Basel, CHE, 4051

Website

https://www.sandoz.com

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as the first US biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in its pipeline.

Sandoz Group AG Headlines

No Headlines